What Is Hypofibrinogenemia and How Is It Treated?

Written by Medicover Team and Medically Reviewed by Dr Nilesh Wasekar , Hematologists

Hypofibrinogenemia is a rare blood clotting disorder characterized by lower-than-normal levels of fibrinogen in the blood. Fibrinogen is a protein produced by the liver that plays a crucial role in blood clot formation, helping the body stop bleeding and support wound healing.

When fibrinogen levels are insufficient, the blood may not clot properly, increasing the risk of excessive bleeding, prolonged bleeding after injuries, or complications during surgery. Hypofibrinogenemia can be inherited from birth or develop later in life due to certain medical conditions, liver disorders, or other underlying factors. Early diagnosis and appropriate treatment are important to reduce bleeding risks and maintain normal clotting function.

What Are the Symptoms of Hypofibrinogenemia?

The symptoms of hypofibrinogenemia vary depending on the level of fibrinogen deficiency and the body's ability to form blood clots. Some individuals may experience mild symptoms, while others may develop significant bleeding problems.

Common symptoms of hypofibrinogenemia include:

• Easy Bruising: Due to compromised clot formation.
• Prolonged Bleeding: Following injuries or surgical procedures.
• Nosebleeds: Frequent and sometimes severe.
• Heavy Menstrual Bleeding: In affected females.
• Bleeding in Joints and Muscles: Though less common, can occur in severe cases.

What Causes Hypofibrinogenemia?

Hypofibrinogenemia can be inherited or acquired. The condition develops when the body produces insufficient fibrinogen or when fibrinogen is consumed faster than it can be replaced.

Genetic and Congenital Factors

Congenital hypofibrinogenemia is often due to genetic mutations affecting the fibrinogen genes, namely FGA, FGB, and FGG. These mutations can result in either decreased production of fibrinogen or production of dysfunctional fibrinogen that is unable to participate effectively in clot formation. The mode of inheritance can be autosomal dominant or recessive, with the latter often resulting in more severe manifestations.

Acquired Factors

Acquired hypofibrinogenemia can result from several conditions that either enhance fibrinogen consumption or impair its production. These include:

When Should You See a Doctor for Hypofibrinogenemia?

Consult a Hematologist if you experience unusual bleeding symptoms, have a family history of blood clotting disorders, or are diagnosed with conditions that may affect fibrinogen levels.

Early diagnosis and treatment can help prevent serious bleeding complications and improve long-term health outcomes.

Find Hematologists for Hypofibrinogenemia Treatment Near You

How Is Hypofibrinogenemia Diagnosed?

Diagnosis of hypofibrinogenemia involves a comprehensive approach, including clinical assessment and laboratory investigations. Key diagnostic steps include:

Fibrinogen Testing

Quantitative fibrinogen assays, such as the Clauss method, are pivotal in determining fibrinogen levels in plasma. Additionally, functional fibrinogen assays can assess the protein ability to form clots.

Genetic Testing

For congenital cases, genetic testing can identify mutations in fibrinogen genes, aiding in diagnosis and guiding family counselling.

Additional Coagulation Tests

Tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) can provide insights into the broader coagulation profile, identifying potential coagulopathies.

What Is the Treatment for Hypofibrinogenemia?

Treatment strategies for hypofibrinogenemia are contingent on the underlying cause and severity of symptoms. Options include:

Fibrinogen Replacement Therapy

This is the cornerstone of treatment, particularly in acute bleeding scenarios or before surgical interventions. Fibrinogen concentrates or cryoprecipitate can be administered to replenish fibrinogen levels rapidly.

Treating Underlying Conditions

Addressing the root cause, whether it be liver disease or a systemic inflammatory condition, can help restore normal fibrinogen levels.

Supportive Measures

In mild cases, supportive care, including antifibrinolytic agents, can help mitigate bleeding risks. Regular monitoring and prophylactic measures during surgeries or invasive procedures are also crucial.

Your health is everything - prioritize your well-being today.

Consult Hypofibrinogenemia Doctors Today

Why Is Genetic Counseling Important for Hypofibrinogenemia?

Genetic counseling can help individuals and families understand the inherited nature of congenital hypofibrinogenemia. It provides information about inheritance patterns, genetic testing, recurrence risks, and family planning options.

Advances in genetic research, gene therapy, and targeted treatments continue to improve the understanding and management of hypofibrinogenemia, offering hope for more effective therapies in the future.

How Is Hypofibrinogenemia Different from Afibrinogenemia?

Hypofibrinogenemia and afibrinogenemia are both rare blood clotting disorders involving fibrinogen deficiency, but they differ in severity.

Hypofibrinogenemia is characterized by reduced levels of fibrinogen in the blood, which can lead to mild to moderate bleeding symptoms. In contrast, afibrinogenemia involves the complete absence of fibrinogen, resulting in a much higher risk of severe and potentially life-threatening bleeding complications.

Accurate diagnosis is important because the treatment approach and long-term management may differ between these conditions.

What Factors Increase the Risk of Hypofibrinogenemia?

Several risk factors predispose individuals to hypofibrinogenemia, including: